Efficacy and Safety Analysis of Transarterial Chemoembolization Plus Donafenib With or Without Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma: A Prospective, Single-Arm, Single-Center, Phase II Clinical Study

Li J, Li Y, Song J, Zhao L

Journal of Hepatocellular Carcinoma 2024, 11:1207-1219

Published Date: 27 June 2024